[HTML][HTML] Targeted radionuclide therapy in endocrine-related cancers: advances in the last decade

T Al-Toubah, J Strosberg… - Frontiers in …, 2023 - frontiersin.org
Targeted radionuclide therapy plays an increasingly important role in managing endocrine-
related tumors and significantly advances the therapeutic landscape for patients with these …

[HTML][HTML] Primary Tumor Resection and Its Implications in the Modern Treatment Era of Metastatic Small Bowel Neuroendocrine Tumors: Editorial on:“Morbidity and …

XM Keutgen - Annals of Surgical Oncology, 2024 - Springer
In this article, Nigam et al. study the important question on whether primary tumor resection
(PTR) in widely metastatic small bowel neuroendocrine tumors (SBNETs) is beneficial at …

Light It Up! The Use of DOTATATE in Diagnosis and Treatment of Neuroendocrine Neoplasms

JL Schwarz, JK Williams… - Surgical Pathology …, 2023 - surgpath.theclinics.com
Radiolabeled somatostatin analogs are increasingly used in the diagnosis and treatment of
neuroendocrine tumors. Diagnostic imaging with 68Ga-DOTATATE PET/CT has …